{"filing":{"accession_number":"0001156039-26-000058","cik":"0001156039","ticker":"ELV","company_name":"Elevance Health, Inc.","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"elv-20260715.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000058/elv-20260715.htm"},"events":[{"id":17981,"run_id":16134,"accession_number":"0001156039-26-000058","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Elevance Health issued a press release on July 15, 2026, reporting second quarter 2026 financial results, including operating revenue of $49.8 billion, diluted EPS of $6.71, and adjusted diluted EPS of $7.45. The company also raised full-year 2026 guidance for diluted EPS to at least $20.10 and adjusted diluted EPS to at least $27.00. This is a standard quarterly earnings release with detailed financial statements, segment performance, and forward guidance—a material disclosure affecting investor assessment of the registrant's financial performance and outlook.","company_name":"Elevance Health, Inc.","ticker":"ELV","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":16651,"accession_number":"0001156039-26-000058","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Elevance Health issued a press release on July 15, 2026, reporting second quarter 2026 financial results, including operating revenue of $49.8 billion, diluted EPS of $6.71, and adjusted diluted EPS of $7.45. The company also raised full-year 2026 guidance for diluted EPS to at least $20.10 and adjusted diluted EPS to at least $27.00. This is a standard quarterly earnings release with detailed financial statements, segment performance, and forward guidance—a material disclosure affecting investor assessment of the registrant's financial performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T10:09:12.211394+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16651,"accession_number":"0001156039-26-000058","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Elevance Health issued a press release on July 15, 2026, reporting second quarter 2026 financial results, including operating revenue of $49.8 billion, diluted EPS of $6.71, and adjusted diluted EPS of $7.45. The company also raised full-year 2026 guidance for diluted EPS to at least $20.10 and adjusted diluted EPS to at least $27.00. This is a standard quarterly earnings release with detailed financial statements, segment performance, and forward guidance—a material disclosure affecting investor assessment of the registrant's financial performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T10:09:12.211394+00:00","company_name":"Elevance Health, Inc.","ticker":"ELV","filing_date":"2026-07-15"}]}